F10基因过表达及沉默对绒癌细胞系JEG-3侵袭性的影响

来源 :中华实用诊断与治疗杂志 | 被引量 : 0次 | 上传用户:yzqp178
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨F10基因过表达及沉默对绒癌细胞系JEG-3侵袭相关蛋白酶表达的影响。方法采用细胞转染技术及RNA干扰技术,分别建立和筛选出F10基因稳定过表达及沉默的绒癌细胞系JEG-3。将SPF级裸鼠(4~5周龄)30只随机分为F10过表达组、F10沉默组和未处理组各10只,分别接种F10基因过表达的JEG-3细胞、F10基因沉默的JEG-3细胞和未处理的JEG-3细胞。于接种5周后处死裸鼠取皮下肿瘤,采用免疫组织化学法和Western blot法检测各组瘤体组织中基质金属蛋白酶(matrix metalloproteinase,MMP)、基质金属蛋白酶组织抑制物-1(tissue inhibitor of matrix metalloproteinase,TIMP-1),血浆纤溶酶原激活物抑制因子(plasminogen activator inhibitor-1,PAI-1)等侵袭相关蛋白酶的表达,并进行比较。结果免疫组织化学结果显示,F10过表达组成瘤组织中MMP-2、MMP-8、MMP-11、MMP-16、MMP-19蛋白表达水平(0.332±0.037、0.473±0.089、0.441±0.031、0.470±0.040、0.548±0.062)高于未处理组(0.209±0.021、0.314±0.108、0.207±0.025、0.400±0.057、0.466±0.038)和F10沉默组(0.049±0.013、0.168±0.034、0.149±0.024、0.240±0.024、0.175±0.029)(P<0.05),未处理组高于F10沉默组(P<0.05);F10过表达组TIMP-1(0.191±0.027)和PAI-1蛋白(0.130±0.020)表达水平低于未处理组(0.249±0.036、0.284±0.020)和F10沉默组(0.310±0.018、0.463±0.115)(P<0.05),未处理组低于F10沉默组(P<0.05)。wesrern blot检测结果显示,上述侵袭相关蛋白酶在3组间比较差异均有统计学意义(P<0.05)。结论 F10通过上调MMP-2、MMP-8、MMP-11、MMP-16、MMP-19表达,下调TIMP-1、PAI-1表达,促进绒癌细胞增殖、侵袭和转移。 Objective To investigate the effect of overexpression of F10 gene and silencing on the expression of protease related to invasion of choriocarcinoma cell line JEG-3. Methods Cell transfection technology and RNA interference technology were used to establish and screen the choriocarcinoma cell line JEG-3 with overexpression and silencing of F10 gene respectively. Thirty SPF nude mice (4 to 5 weeks old) were randomly divided into F10 overexpression group, F10 silencing group and untreated group, 10 mice in each group were inoculated with JEG-3 cells overexpressing F10 gene, JEG -3 cells and untreated JEG-3 cells. The tumors in nude mice were sacrificed 5 weeks after inoculation, and the expression of matrix metalloproteinase (MMP), tissue inhibitor of tissue inhibitor of metalloproteinase (TIMP-1) in each group were detected by immunohistochemistry and Western blot. TIMP-1) and plasminogen activator inhibitor-1 (PAI-1) were detected and compared. Results The results of immunohistochemistry showed that the expression of MMP-2, MMP-8, MMP-11, MMP-16 and MMP-19 in the overexpression group of F10 was significantly higher than that in the control group (0.332 ± 0.037, 0.473 ± 0.089, ± 0.040, 0.548 ± 0.062) were higher than those in the untreated group (0.209 ± 0.021,0.314 ± 0.108,0.207 ± 0.025,0.400 ± 0.057,0.466 ± 0.038) and F10 silencing group (0.049 ± 0.013,0.168 ± 0.034,0.149 ± 0.024, The levels of TIMP-1 (0.191 ± 0.027) and PAI-1 protein (0.130 ± 0.020) in F10 overexpression group were significantly higher than those in F10 silencing group (P <0.05) (P <0.05). The expression levels in the untreated group were lower than those in the F10 silencing group (0.249 ± 0.036,0.284 ± 0.020) and the F10 silencing group (0.310 ± 0.018,0.463 ± 0.115) (P <0.05). The results of wesrern blot showed that there were significant differences among the three groups in invasion-related proteases (P <0.05). Conclusion F10 can promote the proliferation, invasion and metastasis of choriocarcinoma cells by up-regulating the expression of MMP-2, MMP-8, MMP-11, MMP-16 and MMP-19 and down-regulating the expressions of TIMP-1 and PAI-
其他文献
海康县客路公社位于雷州半岛腹地.全社有水旱田71000亩,大部分是黑泥田和沙质坡旱田.土壤干旱瘦瘠,有机质缺乏,保水保肥力差,是我县低产地区之一.过去,这个公社多数是稻、稻
定西县青岚公社大坪大队碾盘生产队,种植小麦面积占粮田面积48%以上,小麦总产占全年粮食总产近一半。因此,抓住小麦丰产成为夺取全年粮食增产的关键。一九七七年,小麦生长期
目的:研究中西医结合治疗与再生障碍性贫血骨髓免疫分型的相关性。   方法;依据张之南主编的《血液病诊断及疗效标准》(第三版)之诊断及疗效标准,对确定诊断的79例再生障碍性贫
2020年11月1日,由欧盟资助的地平线2020 ICT-0535GRAIL项目正式启动.项目为期30个月,预算为1300万欧元,包括8个工作包.项目旨在验证未来铁路移动通信系统(FRMCS)的首批规范,
期刊
温州地区小麦生长后期常遇高温多雨,小麦产量低又不稳。我们以耐病、耐湿、耐肥抗倒为主要矛盾,用友谊麦作母本,科春5号作父本,育成了小麦新品系“169”。据78—79年度22个
目的:通过观察凋膜止崩方对去势雌激素负荷大鼠子宫内膜增生症模型雌激素、雌激素受体及雌激素受体亚型的影响,探索中药靶向干预子宫内膜增生症的分子生物学机制,揭示凋膜止崩方
目的:观察扶肾降浊方对系膜增生性肾炎大鼠生化指标定量、肾脏组织病理学变化以及纤维化因子表达的影响,探讨扶肾降浊方对肾纤维化大鼠肾脏保护作用的可能机制。方法:1.将24
目的:本研究旨在探讨激活蛋白-1(Activator protein-1,AP-1)基因rs1323288,rs2760501多态性与缺血性脑卒中(Ischemic stroke,IS)及其中医证型中风痰瘀阻证、气虚血瘀证遗传易感性
目的探讨二甲双胍对听神经细胞株HEI-OC1放射性损伤的保护作用及可能的分子机制。方法体外培养听神经细胞株HEI-OC1,实验分为正常对照组、照射组、照射+二甲双胍干预组(干预
Cim atron L td.(NASDAQ:CIMT)最近向全世界发布 Cimatron E4 .2版本 ,该版本在 3轴与 5轴铣削、高速加工、设计解决方案方面有了新的改良。改进后的Cim atron E4 .2增加了以